Cardiovascular Clinical Consult

Remission of T2D, regardless of duration of remission, was associated with reduced risk of diabetes-related CKD and CVD in a post hoc analysis of Look AHEAD.

A key opinion leader discusses the most significant unmet needs in the evolving spectrum of cardiovascular risk management.

A discussion on recent data updates from the REDUCE-IT trial, and their practical implications for physicians managing cardiovascular risk.

Cardiologist Deepak Bhatt, MD, discusses factors to consider when assessing the need for cardiovascular risk management or reduction.

A key opinion leader discusses effective CV risk prevention measures, challenges to reducing adverse events, and effective patient education resources.

This article reviews the evolving therapeutic landscape for lowering LDL-C and cardiovascular risk, with an emphasis on the role of omega-3 fatty acids.